Cocktail gene therapy for hepatocellular carcinomaand liver cirrhosis
博士 === 國立臺灣大學 === 臨床醫學研究所 === 99 === Background & Aims: Cytokine and antiangiogenic gene therapies have proven effective in many implanted hepatocellular carcinoma(HCC) models with small tumor burdens. However, these models may not realistically reflect human HCCs, which are typically large, mul...
Main Authors: | Kai-Wen Huang, 黃凱文 |
---|---|
Other Authors: | Lih-Hwa Hwang |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/08684848874119767701 |
Similar Items
-
Angiogenesis in liver cirrhosis and hepatocellular carcinoma
by: Amarapurkar Anjali, et al.
Published: (2008-07-01) -
A case of liver cirrhosis with hepatocellular adenoma
by: QI Chuanwang, et al.
Published: (2017-09-01) -
Predictors of hepatocellular carcinoma in patients with liver cirrhosis
by: Pop Crina, et al.
Published: (2015-03-01) -
Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma
by: Chen Hao Jiang, et al.
Published: (2020-01-01) -
Transarterial Antiangiogenetic Gene Therapy of Hepatocellular Carcinoma during Ischemia Challenge: A Rat Model with Intrahepatic Arterial Catheterization
by: Kai-Wen Huang, et al.
Published: (2003)